|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.38 CNY | +0.09% |
|
+0.47% | +0.80% |
| Capitalization | 4.24B 591M 506M 471M 438M 809M 50.73B 899M 5.64B 2.16B 23.75B 2.22B 2.17B 87.13B | P/E ratio 2025 * |
22.6x | P/E ratio 2026 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise value | 3.02B 421M 360M 335M 312M 577M 36.14B 641M 4.02B 1.54B 16.92B 1.58B 1.55B 62.07B | EV / Sales 2025 * |
4.05x | EV / Sales 2026 * | 3.52x |
| Free-Float |
55.14% | Yield 2025 * |
1.36% | Yield 2026 * | 1.57% |
More valuation ratios
* Estimated data
More news
| 1 day | +0.09% | ||
| 1 week | +0.47% | ||
| Current month | +0.23% | ||
| 1 month | -3.65% | ||
| 3 months | +10.26% | ||
| 6 months | +9.58% | ||
| Current year | +0.80% |
| 1 week | 21.11 |  | 21.49 |
| 1 month | 20.83 | | 23.5 |
| Current year | 18.22 | | 23.66 |
| 1 year | 18.22 | | 27.13 |
| 3 years | 18.22 | | 58.66 |
| 5 years | 18.22 | | 58.66 |
| 10 years | 10.65 | | 58.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Yu Li
CEO | Chief Executive Officer | 34 | 2022-04-21 |
Biao Zhu
DFI | Director of Finance/CFO | 52 | 2021-12-05 |
Jing Xu
PRN | Corporate Officer/Principal | 40 | 2019-04-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Yan Li
CHM | Chairman | 65 | 1997-03-02 |
Zhen Hao Li
BRD | Director/Board Member | 38 | 2013-05-24 |
Ling Juan Hu
BRD | Director/Board Member | 38 | 2017-02-11 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.09% | +0.47% | -6.68% | -47.53% | 591M | ||
| +0.60% | -1.19% | -9.23% | +32.61% | 4.53B | ||
| +0.07% | -0.53% | -4.48% | -45.09% | 3.48B | ||
| -0.08% | +0.69% | -17.57% | +5.34% | 3.37B | ||
| -0.25% | -0.50% | +22.87% | +52.26% | 3.3B | ||
| +0.73% | +2.28% | +3.01% | +38.94% | 3.12B | ||
| +0.42% | +1.56% | +8.83% | -13.21% | 2.49B | ||
| +1.67% | -0.68% | +25.58% | +85.90% | 1.82B | ||
| -0.26% | -2.64% | -3.94% | +92.44% | 1.8B | ||
| -0.25% | +0.25% | +25.95% | -46.36% | 1.67B | ||
| Average | +0.27% | +0.60% | +4.43% | +15.53% | 2.62B | |
| Weighted average by Cap. | +0.28% | +0.57% | +2.64% | +18.63% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 746M 104M 88.93M 82.83M 77.04M 142M 8.92B 158M 993M 379M 4.18B 390M 382M 15.32B | 812M 113M 96.92M 90.28M 83.97M 155M 9.72B 172M 1.08B 414M 4.55B 425M 416M 16.7B |
| Net income | 187M 26.09M 22.31M 20.78M 19.33M 35.71M 2.24B 39.68M 249M 95.19M 1.05B 97.84M 95.82M 3.84B | 215M 29.99M 25.65M 23.89M 22.22M 41.05M 2.57B 45.62M 286M 109M 1.2B 112M 110M 4.42B |
| Net Debt | -1.22B -170M -145M -135M -126M -233M -14.59B -259M -1.62B -621M -6.83B -638M -625M -25.06B | -1.38B -193M -165M -154M -143M -264M -16.54B -293M -1.84B -703M -7.74B -723M -708M -28.41B |
More financial data
* Estimated data
Employees
1,118
Sector
Pharmaceuticals
Calendar
Aug. 27
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 21.38 ¥ | +0.09% | 2,444,800 |
| 25-07-10 | 21.36 ¥ | +0.47% | 1,950,000 |
| 25-07-09 | 21.26 ¥ | 0.00% | 2,243,853 |
| 25-07-08 | 21.26 ¥ | +0.62% | 1,985,230 |
| 25-07-07 | 21.13 ¥ | -0.70% | 1,830,600 |
End-of-day quote Shanghai S.E., July 10, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
21.38CNY
Average target price
27.60CNY
Spread / Average Target
+29.09%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603896 Stock
Select your edition
All financial news and data tailored to specific country editions
